Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.

Conditions:   Crohn Disease;   Ulcerative Colitis Interventions:   Drug: Amgevita 40Mg Solution for Injection;   Drug: HUMIRA 40Mg Solution for Injection Sponsor:   Fundación Pública Andaluza para la gestión de la Investigación en Sevilla Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials